• Citer

A quantitative approach to benefit-risk assessment of medicines - Part 1: The development of a new model using multi-criteria decision analysis; part 2: The practical application of a new model

par Abadie, Éric E.;Alvan, Gunnar;Breckenridge, Alasdair;Flamion, Bruno ;Jefferys, David;Mussen, Filip;Salek, Sam S.S.;Walker, Stuart
Référence Pharmacoepidemiology and drug safety, 16, SUPPL. 1, page (S42-S46)
Publication Publié, 2007-07

Article révisé par les pairs

• Accès en ligne
• Détails
• Statistiques

Titre:	A quantitative approach to benefit-risk assessment of medicines - Part 1: The development of a new model using multi-criteria decision analysis; part 2: The practical application of a new model
Auteur:	Abadie, Éric E.; Alvan, Gunnar; Breckenridge, Alasdair; Flamion, Bruno; Jefferys, David; Mussen, Filip; Salek, Sam S.S.; Walker, Stuart
Informations sur la publication:	Pharmacoepidemiology and drug safety, 16, SUPPL. 1, page (S42-S46)
Statut de publication:	Publié, 2007-07
Sujet CREF:	Pharmacologie
	Epidémiologie
Note générale:	SCOPUS: no.j
	FLWIN
Langue:	Anglais
Identificateurs:	urn:issn:1053-8569
	info:doi/10.1002/pds.1436
	info:scp/34547546947
	info:pmid/17546572